Rallybio Corp (United States) is listed on the Nasdaq and has a market capitalization of $96.49 million, with shareholders equity totaling $94.50 million.
The company employs approximately 7 people and operates in the Others sector, within the Others industry.
Over the past 12 months, Rallybio Corp reported $646.00 Thousand in revenue, generating net income of $45.55 million.
Key financial metrics include a P/E ratio of 2.12, a price-to-book (P/B) ratio of 1.02, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker RLYB.